/Becton%20Dickinson%20%26%20Co_%20logo%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Valued at a market cap of $50.3 billion, Becton, Dickinson and Company (BDX) is a global medical technology leader based in Franklin Lakes, New Jersey. It develops, manufactures, and sells a comprehensive range of medical supplies, devices, and interventional solutions.
Companies valued at $10 billion or more are typically classified as “large-cap stocks,” and BDX fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the medical instruments & supplies industry. By prioritizing innovation in high-growth fields such as biologic drug delivery, automated medication management, and advanced patient monitoring, the company continues to advance the world of health by improving clinical outcomes and operational efficiency for providers and patients.